Nyxoah S.A (NYXH): יחס שווי שוק להכנסות החברה

P/S levels on the chart help assess the business valuation relative to revenue, with 2.80 representing the most recent level. Nyxoah S.A. (NYXH) operates within a stable Western jurisdiction free from political threats. Growth is expected following FDA approval of the Genio system and the expansion of insurance coverage. However, slow adoption of neurostimulation and pressure from traditional therapy methods create certain commercial risks.
פילוחי מדדים ואנליטיקה של חברת Nyxoah (NYXH)

The P/S ratio determines the market value of a business relative to its annual sales volume, allowing for an assessment of the premium paid for every dollar of revenue. By analyzing the P/S trajectory, an investor compares the market capitalization of Nyxoah S.A. (NYXH) with the sales efficiency of its apnea therapy implants, while accounting for costs associated with environmental production upgrades and the disposal of specific medical waste.